nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1B—artery—metabolic syndrome X	0.0384	0.203	CbGeAlD
Frovatriptan—HTR1D—artery—metabolic syndrome X	0.0371	0.197	CbGeAlD
Frovatriptan—Toothache—Metformin—metabolic syndrome X	0.0323	0.0746	CcSEcCtD
Frovatriptan—HTR1B—blood vessel—metabolic syndrome X	0.0299	0.158	CbGeAlD
Frovatriptan—HTR1D—blood vessel—metabolic syndrome X	0.0289	0.153	CbGeAlD
Frovatriptan—Rigors—Metformin—metabolic syndrome X	0.0241	0.0556	CcSEcCtD
Frovatriptan—Chest discomfort—Metformin—metabolic syndrome X	0.0222	0.0513	CcSEcCtD
Frovatriptan—Ear pain—Metformin—metabolic syndrome X	0.0167	0.0386	CcSEcCtD
Frovatriptan—Hypoglycaemia—Metformin—metabolic syndrome X	0.0146	0.0338	CcSEcCtD
Frovatriptan—Pain in extremity—Metformin—metabolic syndrome X	0.0143	0.033	CcSEcCtD
Frovatriptan—Migraine—Metformin—metabolic syndrome X	0.014	0.0324	CcSEcCtD
Frovatriptan—HTR1B—cardiovascular system—metabolic syndrome X	0.0133	0.0705	CbGeAlD
Frovatriptan—Dehydration—Metformin—metabolic syndrome X	0.0133	0.0306	CcSEcCtD
Frovatriptan—HTR1D—cardiovascular system—metabolic syndrome X	0.0129	0.0683	CbGeAlD
Frovatriptan—HTR1D—kidney—metabolic syndrome X	0.0126	0.0668	CbGeAlD
Frovatriptan—Sweating increased—Metformin—metabolic syndrome X	0.012	0.0277	CcSEcCtD
Frovatriptan—HTR1A—cardiovascular system—metabolic syndrome X	0.0108	0.0569	CbGeAlD
Frovatriptan—Bradycardia—Metformin—metabolic syndrome X	0.01	0.0232	CcSEcCtD
Frovatriptan—Rhinitis—Metformin—metabolic syndrome X	0.00989	0.0229	CcSEcCtD
Frovatriptan—Hypoaesthesia—Metformin—metabolic syndrome X	0.00982	0.0227	CcSEcCtD
Frovatriptan—Flushing—Metformin—metabolic syndrome X	0.00916	0.0212	CcSEcCtD
Frovatriptan—Chills—Metformin—metabolic syndrome X	0.00885	0.0205	CcSEcCtD
Frovatriptan—Malnutrition—Metformin—metabolic syndrome X	0.00859	0.0198	CcSEcCtD
Frovatriptan—Flatulence—Metformin—metabolic syndrome X	0.00846	0.0196	CcSEcCtD
Frovatriptan—Dysgeusia—Metformin—metabolic syndrome X	0.00841	0.0194	CcSEcCtD
Frovatriptan—Muscle spasms—Metformin—metabolic syndrome X	0.00826	0.0191	CcSEcCtD
Frovatriptan—Tremor—Metformin—metabolic syndrome X	0.00805	0.0186	CcSEcCtD
Frovatriptan—Ill-defined disorder—Metformin—metabolic syndrome X	0.00797	0.0184	CcSEcCtD
Frovatriptan—Malaise—Metformin—metabolic syndrome X	0.00775	0.0179	CcSEcCtD
Frovatriptan—Syncope—Metformin—metabolic syndrome X	0.0077	0.0178	CcSEcCtD
Frovatriptan—Palpitations—Metformin—metabolic syndrome X	0.00759	0.0175	CcSEcCtD
Frovatriptan—Loss of consciousness—Metformin—metabolic syndrome X	0.00755	0.0174	CcSEcCtD
Frovatriptan—Chest pain—Metformin—metabolic syndrome X	0.00731	0.0169	CcSEcCtD
Frovatriptan—Myalgia—Metformin—metabolic syndrome X	0.00731	0.0169	CcSEcCtD
Frovatriptan—Discomfort—Metformin—metabolic syndrome X	0.00723	0.0167	CcSEcCtD
Frovatriptan—Shock—Metformin—metabolic syndrome X	0.0069	0.0159	CcSEcCtD
Frovatriptan—Hyperhidrosis—Metformin—metabolic syndrome X	0.00678	0.0157	CcSEcCtD
Frovatriptan—Anorexia—Metformin—metabolic syndrome X	0.00668	0.0154	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00639	0.0148	CcSEcCtD
Frovatriptan—Paraesthesia—Metformin—metabolic syndrome X	0.0063	0.0145	CcSEcCtD
Frovatriptan—Dyspnoea—Metformin—metabolic syndrome X	0.00625	0.0144	CcSEcCtD
Frovatriptan—Somnolence—Metformin—metabolic syndrome X	0.00623	0.0144	CcSEcCtD
Frovatriptan—Dyspepsia—Metformin—metabolic syndrome X	0.00617	0.0143	CcSEcCtD
Frovatriptan—Decreased appetite—Metformin—metabolic syndrome X	0.00609	0.0141	CcSEcCtD
Frovatriptan—Fatigue—Metformin—metabolic syndrome X	0.00604	0.014	CcSEcCtD
Frovatriptan—Constipation—Metformin—metabolic syndrome X	0.006	0.0139	CcSEcCtD
Frovatriptan—Feeling abnormal—Metformin—metabolic syndrome X	0.00578	0.0133	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00573	0.0132	CcSEcCtD
Frovatriptan—Abdominal pain—Metformin—metabolic syndrome X	0.00554	0.0128	CcSEcCtD
Frovatriptan—CYP1A2—liver—metabolic syndrome X	0.00507	0.0268	CbGeAlD
Frovatriptan—Asthenia—Metformin—metabolic syndrome X	0.00503	0.0116	CcSEcCtD
Frovatriptan—Pruritus—Metformin—metabolic syndrome X	0.00496	0.0115	CcSEcCtD
Frovatriptan—Diarrhoea—Metformin—metabolic syndrome X	0.0048	0.0111	CcSEcCtD
Frovatriptan—Dizziness—Metformin—metabolic syndrome X	0.00464	0.0107	CcSEcCtD
Frovatriptan—Vomiting—Metformin—metabolic syndrome X	0.00446	0.0103	CcSEcCtD
Frovatriptan—Headache—Metformin—metabolic syndrome X	0.00439	0.0101	CcSEcCtD
Frovatriptan—Nausea—Metformin—metabolic syndrome X	0.00416	0.00962	CcSEcCtD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00151	0.00399	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.0015	0.00398	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.0015	0.00396	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.00147	0.00389	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.00145	0.00383	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.00144	0.00379	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00134	0.00355	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00131	0.00346	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GGT1—metabolic syndrome X	0.00129	0.00341	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00128	0.00339	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00128	0.00339	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—AGT—metabolic syndrome X	0.00126	0.00333	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00125	0.00331	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—GHRL—metabolic syndrome X	0.00124	0.00328	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—AGT—metabolic syndrome X	0.00123	0.00326	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00122	0.00321	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—GHRL—metabolic syndrome X	0.00121	0.00321	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.0012	0.00316	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CNR1—metabolic syndrome X	0.00117	0.00311	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00117	0.0031	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00115	0.00304	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CNR1—metabolic syndrome X	0.00115	0.00304	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.00112	0.00297	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	0.00101	0.00266	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.001	0.00264	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000979	0.00259	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000976	0.00258	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000949	0.00251	CbGpPWpGaD
Frovatriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000943	0.00249	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000938	0.00248	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00093	0.00246	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.000925	0.00245	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL5—metabolic syndrome X	0.000911	0.00241	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000892	0.00236	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL5—metabolic syndrome X	0.000892	0.00236	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.000876	0.00232	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000862	0.00228	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000844	0.00223	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000824	0.00218	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000807	0.00213	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—AGT—metabolic syndrome X	0.000762	0.00201	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.000754	0.00199	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000751	0.00199	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000746	0.00197	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—AGT—metabolic syndrome X	0.000746	0.00197	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00074	0.00196	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.000729	0.00193	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000724	0.00191	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000708	0.00187	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000701	0.00185	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000686	0.00182	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.00068	0.0018	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.00068	0.0018	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.000679	0.0018	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000672	0.00178	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000664	0.00176	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000658	0.00174	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00065	0.00172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000643	0.0017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—GHRL—metabolic syndrome X	0.000637	0.00168	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL2—metabolic syndrome X	0.000627	0.00166	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—GHRL—metabolic syndrome X	0.000623	0.00165	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000614	0.00162	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL2—metabolic syndrome X	0.000614	0.00162	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CNR1—metabolic syndrome X	0.000603	0.00159	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.0006	0.00159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CNR1—metabolic syndrome X	0.00059	0.00156	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.00059	0.00156	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HDAC3—metabolic syndrome X	0.00057	0.00151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000569	0.0015	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—AGT—metabolic syndrome X	0.000568	0.0015	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000558	0.00147	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000552	0.00146	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000523	0.00138	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000515	0.00136	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000509	0.00135	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000504	0.00133	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000501	0.00132	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000499	0.00132	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TRIB3—metabolic syndrome X	0.000496	0.00131	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RBP4—metabolic syndrome X	0.000496	0.00131	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000495	0.00131	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000495	0.00131	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000486	0.00128	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RBP4—metabolic syndrome X	0.000486	0.00128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000484	0.00128	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000476	0.00126	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000475	0.00126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000469	0.00124	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000468	0.00124	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL5—metabolic syndrome X	0.000467	0.00124	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000466	0.00123	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000464	0.00123	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL5—metabolic syndrome X	0.000458	0.00121	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000456	0.00121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00045	0.00119	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOC3—metabolic syndrome X	0.00044	0.00116	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000431	0.00114	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AGT—metabolic syndrome X	0.00043	0.00114	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOC3—metabolic syndrome X	0.00043	0.00114	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000425	0.00112	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000421	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2C—metabolic syndrome X	0.000397	0.00105	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AGT—metabolic syndrome X	0.000391	0.00103	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000388	0.00103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000384	0.00102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CYBA—metabolic syndrome X	0.000384	0.00102	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000384	0.00101	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AGT—metabolic syndrome X	0.000383	0.00101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000382	0.00101	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00038	0.001	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CYBA—metabolic syndrome X	0.000376	0.000995	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GHRL—metabolic syndrome X	0.000376	0.000994	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FMO3—metabolic syndrome X	0.000375	0.000992	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000371	0.000981	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RBP4—metabolic syndrome X	0.00037	0.000979	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00037	0.000979	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GHRL—metabolic syndrome X	0.000368	0.000974	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CNR1—metabolic syndrome X	0.000356	0.000942	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000355	0.000939	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CNR1—metabolic syndrome X	0.000349	0.000922	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000349	0.000922	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000347	0.000918	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000345	0.000912	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000335	0.000887	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	0.000334	0.000884	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	0.000334	0.000884	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000328	0.000867	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL2—metabolic syndrome X	0.000322	0.000851	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000321	0.000849	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000315	0.000834	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	0.000314	0.000831	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000299	0.00079	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000296	0.000782	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000292	0.000771	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF2—metabolic syndrome X	0.000291	0.00077	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.00029	0.000766	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000287	0.000758	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF2—metabolic syndrome X	0.000285	0.000754	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOB—metabolic syndrome X	0.000283	0.000747	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000281	0.000742	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOB—metabolic syndrome X	0.000277	0.000732	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL5—metabolic syndrome X	0.000276	0.00073	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000275	0.000727	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL5—metabolic syndrome X	0.00027	0.000715	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LPL—metabolic syndrome X	0.00027	0.000714	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000269	0.000712	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FABP4—metabolic syndrome X	0.000267	0.000707	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000266	0.000702	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LPL—metabolic syndrome X	0.000264	0.000699	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	0.000253	0.00067	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000246	0.00065	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00024	0.000635	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000239	0.000632	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000235	0.00062	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—metabolic syndrome X	0.000231	0.000611	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—metabolic syndrome X	0.000226	0.000598	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—metabolic syndrome X	0.000226	0.000598	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—metabolic syndrome X	0.000226	0.000598	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—G6PD—metabolic syndrome X	0.000226	0.000597	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—metabolic syndrome X	0.000224	0.000591	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000223	0.000589	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—metabolic syndrome X	0.000222	0.000586	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—metabolic syndrome X	0.000222	0.000586	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	0.00022	0.000583	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—metabolic syndrome X	0.000219	0.000579	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000217	0.000574	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCKR—metabolic syndrome X	0.000215	0.00057	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPA—metabolic syndrome X	0.000215	0.00057	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOB—metabolic syndrome X	0.000211	0.000558	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	0.000209	0.000552	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000207	0.000548	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA5—metabolic syndrome X	0.000207	0.000546	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	0.000206	0.000544	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000205	0.000542	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS1—metabolic syndrome X	0.000202	0.000534	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	0.000201	0.000532	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000201	0.000531	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS1—metabolic syndrome X	0.000198	0.000523	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000197	0.00052	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000194	0.000514	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—metabolic syndrome X	0.000193	0.000511	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	0.000192	0.000508	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—metabolic syndrome X	0.00019	0.000503	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—metabolic syndrome X	0.000189	0.0005	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—metabolic syndrome X	0.000187	0.000494	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—metabolic syndrome X	0.000186	0.000492	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—metabolic syndrome X	0.000183	0.000484	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000178	0.000469	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000174	0.00046	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	0.000172	0.000456	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	0.000172	0.000455	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000171	0.000453	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LIPC—metabolic syndrome X	0.000171	0.000453	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCK—metabolic syndrome X	0.000171	0.000453	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOC3—metabolic syndrome X	0.00017	0.00045	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	0.00017	0.000448	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	0.000169	0.000446	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	0.000169	0.000446	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	0.000167	0.000441	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	0.000166	0.000439	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CETP—metabolic syndrome X	0.000165	0.000437	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	0.000158	0.000418	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000154	0.000407	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	0.000154	0.000406	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	0.000151	0.000398	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT2—metabolic syndrome X	0.000149	0.000395	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	0.000149	0.000395	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000145	0.000384	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—metabolic syndrome X	0.000144	0.000381	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	0.000143	0.000378	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000142	0.000376	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	0.000142	0.000375	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	0.00014	0.00037	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	0.000139	0.000369	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000135	0.000356	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	0.000133	0.000352	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	0.000133	0.000352	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000132	0.00035	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	0.000132	0.000349	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000129	0.000342	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT1—metabolic syndrome X	0.000129	0.000341	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GGT1—metabolic syndrome X	0.000129	0.000341	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	0.000126	0.000334	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	0.000112	0.000296	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	0.00011	0.00029	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOB—metabolic syndrome X	0.000109	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000108	0.000286	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	0.000107	0.000282	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	0.000106	0.000281	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—metabolic syndrome X	0.000104	0.000276	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD36—metabolic syndrome X	9.93e-05	0.000262	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	9.84e-05	0.00026	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARA—metabolic syndrome X	9.23e-05	0.000244	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—metabolic syndrome X	8.94e-05	0.000236	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—metabolic syndrome X	8.76e-05	0.000232	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—metabolic syndrome X	8.66e-05	0.000229	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	8.45e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	8.36e-05	0.000221	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	8.27e-05	0.000219	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	7.79e-05	0.000206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	7.63e-05	0.000202	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—metabolic syndrome X	7.63e-05	0.000202	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—metabolic syndrome X	7.48e-05	0.000198	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—metabolic syndrome X	6.86e-05	0.000181	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—metabolic syndrome X	6.56e-05	0.000173	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	6.3e-05	0.000167	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	6e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.81e-05	0.000154	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—metabolic syndrome X	3.02e-05	7.97e-05	CbGpPWpGaD
